The Industry Special Interest Group (I-SIG) members are a diverse group of researchers from the pharmaceutical and device industry, academia and consulting, who share a common interest in the application of patient-centered outcomes, including health-related quality of life (HRQOL), in research important to industry.
We are interested in innovative methods and research in patient-centered outcomes measurement for use in research important to industry.
The purpose of the I-SIG is to synthesize, share, promote and educate on industry-related patient-centered outcomes research by bringing individuals together who are interested in topics of joint interest to industry and ISOQOL.
Our specific goals are to:
2018 Annual Symposium:
Topic to be determined
Past Symposium Topics:
2017: Real-world evidence to support approval and reimbursement: new frontier?
2016: Incorporating the patient voice in benefit risk assessment and regulatory/HTA decision making
2015: Bring Your Own Device (BYOD): trends, best practices, challenges….where do PRO measures go from here?
2014: Advancing Measurement Science Beyond PROs: Patient-Centeredness and Validity Across All Clinical Outcome Assessments
2013: Innovations for Patient Engagement in Health Outcomes Development, Selection and Measurement: Opportunities and Limitations
2012: Perspectives on Mixed Methods to Assess Content Validity of a Patient Reported Outcome
2011: To Qualify or Not to Qualify: Benefits and Challenges of PRO Instrument Qualification from Industry, Academic, and Regulatory Perspectives
We encourage active communication between members.
Watch here for announcements of upcoming webinars.
Interpretation of PRO Data within Clinical Trials (not available via website)
Emuella Flood is a Senior Principal within ICON Clinical Outcomes Assessments (COA) and leads the US East Coast COA team in Gaithersburg, Maryland. She began her career in COA research nearly 20 years ago at MEDTAP International / UBC (now Evidera) before joining Oxford Outcomes in 2006 and ICON in 2011 through acquisition. Emuella has directed the development of COAs, patient preference/conjoint and satisfaction surveys, and patient and caregiver-reported burden of illness surveys for both adult and pediatric populations and across numerous therapeutic areas. She has extensive experience in qualitative research and has presented on best practices at COA professional conferences. In addition to co-chairing the I-SIG, Emuella leads the DIA Study Endpoints Community Educational Series Committee, is a member of the Patient Preference Methodology Working Group of the Medical Device Innovation Consortium (MDIC), and is on the editorial board of The Patient. She has contributed to over 80 peer-reviewed papers and abstracts.